LUMOS2: Low & Anaplastic Grade Glioma Umbrella Study of Molecular Guided TherapieS
ACTRN 12623000096651 Brief Summary This study aims to evaluate a new approach…
Read more arrow_forwardACTRN 12623000096651 Brief Summary This study aims to evaluate a new approach…
Read more arrow_forwardNCT 06097728 Brief Summary This is a phase III, randomized, open-label, multicenter,…
Read more arrow_forwardNCT 05286788 Brief Summary MEKTOVI (binimetinib) is an oral, highly selective…
Read more arrow_forwardNCT 03860883 Brief Summary Patients with a primary invasive melanoma are recommended…
Read more arrow_forwardNCT 05462236 Brief Summary The study is a 2-part study of Tinodasertib…
Read more arrow_forwardNCT 02645149 Brief Summary This is a patient oriented translational research project…
Read more arrow_forwardNCT 03787602 Brief Summary This study evaluates KRT-232, a novel oral small…
Read more arrow_forwardNCT 04830124 Brief Summary This study observes the antitumor activity, safety,…
Read more arrow_forwardNCT 05024318 Brief Summary This is a prospective, open label, phase II,…
Read more arrow_forwardNCT 05025813 Brief Summary Cutaneous Squamous Cell Carcinoma (cSCC) is typically…
Read more arrow_forward